Here are four updates from gastroenterology companies this past week:
Five healthcare facilities recently signed on to adopt Fujifilm's Eluxeo Endoscopic Visualization System, including two endoscopy centers and an ASC.
A phase 1 clinical trial found that Landos Biopharma's Crohn's disease and ulcerative colitis treatment, BT-11, was well-tolerated with no dose-limiting toxicities or detectable systemic immunosuppression.
Modernizing Medicine Gastroenterology improved its gGastro EHR through a collaboration with Change Healthcare.
Exact Sciences' Cologuard can improve colorectal cancer screening rates, according to a study published in Gastroenterology.